Published in Lancet on December 15, 1973
Beta-adrenergic receptor blocking drugs in hypertension. Drugs (1974) 2.18
Management of raised blood pressure. N Z Med J (1994) 2.03
Prazosin in normal subjects: plasma levels, blood pressure and heart rate. Br J Clin Pharmacol (1976) 1.75
Cardiovascular effects of prazosin in normotensive and genetically hypertensive rats. Clin Exp Pharmacol Physiol (1975) 1.63
The Milton survey: Part 1, General methods, height, weight and 24-hour excretion of sodium, potassium, calcium, magnesium and creatinine. N Z Med J (1978) 1.55
The use of p-phenylenediamine in the block to enhance osmium staining for electron microscopy. Stain Technol (1972) 1.47
The relationship between the transverse tubular system and other tubules at the Z disc levels of myocardial cells in the ferret. Am J Anat (1968) 1.42
Surface features of striated muscle. II. Guinea-pig skeletal muscle. J Cell Sci (1968) 1.34
Practolol treatment in asthmatics. Lancet (1971) 1.30
The prevalence of headache in a small New Zealand town. Headache (1985) 1.22
The fine structure of autonomic neuromuscular contacts in arterioles of sheep renal cortex. J Anat (1966) 1.21
Cigarettes and accelerated hypertension. N Z Med J (1980) 1.19
Surface features of smooth muscle cells from the mesenteric artery and vas deferens. J Cell Sci (1971) 1.14
Surface features of striated muscle. I. Guinea-pig cardiac muscle. J Cell Sci (1968) 1.06
A pilot study to test the feasibility of salt restriction in a community. N Z Med J (1982) 1.03
Letter: Paradoxical effect of pindolol. Br Med J (1975) 1.03
Freeze-etch studies on fish skeletal muscle. J Cell Sci (1970) 1.02
Ultrastructure of desmosomes in mammalian intercalated disc; appearances after lanthanum treatment. J Cell Biol (1969) 1.00
A preliminary clinical trial of Prazosin: a new oral antihypertensive agent. N Z Med J (1974) 0.99
The fine structure of vascular sympathetic neuromuscular contacts in the rat. Am J Anat (1967) 0.99
Beta-blockers and lipid metabolism. Br Med J (1977) 0.98
Transverse tubule apertures in mammalian myocardial cells: surface array. Science (1967) 0.98
Experience with labetalol in hypertension. Br J Clin Pharmacol (1976) 0.97
Treatment of hypertension with labetalol. N Z Med J (1977) 0.97
Congenital Abnormalities of the Heart in the Insane. J Anat Physiol (1898) 0.96
Pindolol: a comparison with other antihypertensive drugs and a double-blind placebo trial. N Z Med J (1974) 0.95
Different associations of blood pressure with 24-hour urinary sodium excretion among pre- and post-menopausal women. WHO Cardiovascular Diseases and Alimentary Comparison (WHO-CARDIAC) Study. J Hypertens (2001) 0.93
Ticrynafen: kinetics, protein binding, and effects on serum and urinary uric acid. Clin Pharmacol Ther (1978) 0.93
Localization of tritiated norepinephrine in vascular sympathetic axons of the rat intestine and mesentery by electron microscope radioautography. J Cell Biol (1968) 0.92
Salt and hypertension: a sceptical review of the evidence. Clin Sci (Lond) (1979) 0.91
Further surveys in Milton, 1978 and 1981: blood pressure, height, weight and 24-hour excretion of sodium and potassium. N Z Med J (1982) 0.91
Comparison of tienilic acid with cyclopenthiazide in hyperuricaemic hypertensive patients. Lancet (1978) 0.91
The Milton Survey. 2. Blood pressure and heart rate. N Z Med J (1978) 0.90
Plasma volume, extracellular fluid volume and exchangeable sodium concentrations in the New Zealand strain of genetically hypertensive rat. Clin Sci (1973) 0.89
Salt and hypertension: current data, attitudes, and policies. J Cardiovasc Pharmacol (1984) 0.88
Relationship of blood pressure to sodium excretion in a population survey. Clin Sci Mol Med Suppl (1978) 0.88
Fenfluramine in obese patients on various antihypertensive drugs. Double-blind controlled trial. Lancet (1969) 0.87
Clinical studies with ketanserin in hypertension. J Cardiovasc Pharmacol (1985) 0.85
Effects of different diuretics on urinary calcium excretion in a general population. Aust N Z J Med (1978) 0.85
Myofilaments in frozen-etched muscle. Nature (1968) 0.84
The morphological basis for the sympathetic control of blood vessels. N Z Med J (1968) 0.84
Hypertension and depression: interrelated problems in therapy. J R Coll Physicians Lond (1971) 0.82
Effects of prazosin in patients with hypertension. Clin Pharmacol Ther (1976) 0.82
Alcohol consumption and blood pressure in a New Zealand community study. N Z Med J (1985) 0.80
Selenium and risk factors for cardiovascular disease in New Zealand. N Z Med J (1983) 0.80
Salt appetite, body sodium, handling of a NaCl load, renin, and aldosterone in genetically and spontaneously hypertensive rats. J Cardiovasc Pharmacol (1990) 0.79
Freeze-etch studies on the innervation of mesenteric arteries and vas deferens. J Cell Sci (1971) 0.79
Clonidine in menopausal flushing: a double-blind trial. N Z Med J (1975) 0.79
Iodide excretion in a salt-restriction trial. N Z Med J (1984) 0.79
Review of long-term treatment with labetalol. Br J Clin Pharmacol (1982) 0.78
Total ban on tienilic acid. Lancet (1980) 0.78
One year follow-up of hyperuricaemic hypertensive patients treated with tienilic acid or a diuretic with or without uric acid-lowering drugs. Clin Sci (Lond) (1979) 0.78
Use of prazosin at the dunedin hypertension clinic controlled and open studies and pharmacokinetic observations. Med J Aust (1977) 0.78
FINE STRUCTURE OF CELLS ISOLATED FROM ADULT MOUSE LIVER. J Cell Biol (1962) 0.78
Studies on the New Zealand strain of genetically hypertensive rats. Clin Sci Mol Med Suppl (1973) 0.77
Monovalent and divalent cations in hypertension. Prev Med (1985) 0.77
Discriminant function analysis of factors related to myocardial infarction in male patients on antihypertensive therapy. Br Heart J (1976) 0.77
Licorice consumption among high school students. N Z Med J (1982) 0.76
Comparison of various genetic hypertensive rat strains. J Hypertens Suppl (1986) 0.76
Evidence against a circulating ouabain-like transport inhibitor as a cause of increased red cell sodium in essential hypertension. J Hypertens Suppl (1984) 0.75
Increased plasma volume in hypertensive rats with polyarteritis. Br J Exp Pathol (1974) 0.75
Bundles of intracellular tubules in renal medullary interstitial cells. J Cell Biol (1973) 0.75
Hypertension. Br Med J (1978) 0.75
Letter: New vasodilator drugs for hypertension. Br Med J (1974) 0.75
MRC trial of treatment of mild hypertension. Br Med J (Clin Res Ed) (1985) 0.75
Evidence for safety of new drugs. Br J Clin Pharmacol (1977) 0.75
Guidelines for antihypertensive therapy: problems with a strategy based on absolute cardiovascular risk, reply to comments. J Hypertens (1997) 0.75
The management of hypertension. N Z Med J (1995) 0.75
Relationship of treatment for hypertension and stroke mortality. Stroke (1989) 0.75
Risk predictors in treated hypertension. J Cardiovasc Pharmacol (1990) 0.75
Handling of a salt load by hypertensive and normotensive rats on normal and low intakes of sodium. J Hypertens (1984) 0.75
What do middle-aged New Zealanders eat? A dietary survey in 50-54 year olds in south Canterbury and north Otago. N Z Med J (1988) 0.75
Effect of enalapril on body sodium and handling of a sodium chloride load in hypertensive and normotensive rats. Clin Exp Pharmacol Physiol (1992) 0.75
The structural basis for excitation-contraction coupling in mammalian myocardial cells. Isr J Med Sci (1969) 0.75
Support for South African paediatricians. Lancet (1988) 0.75
Tricyclic antidepressants and the vascular system. N Z Med J (1972) 0.75
Coronary heart disease: prevention and control in 1983. N Z Med J (1983) 0.75
Body sodium level in hypertensive and normotensive rats: effects of dietary sodium levels and sodium loads. J Cardiovasc Pharmacol (1984) 0.75
Trends in hospital bed use by patients with hypertension. N Z Med J (1988) 0.75
Eight-year survival study of treated hypertension at the Dunedin Hypertension Clinic 1953-1977. J Hypertens Suppl (1988) 0.75
Body sodium in rats: response to DOCA, adrenalectomy, changes in salt intake, and a salt load. Am J Physiol (1986) 0.75
The aetiology of essential hypertension. Ann Acad Med Singapore (1981) 0.75
Evaluation of xenon-133 renal blood flow measurement in the intact rat. Am J Physiol (1983) 0.75
Electrolytes and spontaneous genetic hypertension in rats. J Hypertens Suppl (1986) 0.75
Combined potassium-diuretic preparations. N Z Med J (1982) 0.75
Salt and hypertension. N Z Med J (1982) 0.75
Combination antihypertensive therapy. Cardiovasc Clin (1971) 0.75
Control of hypertension. N Z Med J (1988) 0.75
Renal vasculature and hypertensive mechanisms. Histological aspects. Circ Res (1970) 0.75
The evolution of antihypertensive therapy. N Z Med J (1968) 0.75
A questionnaire survey of symptoms in a hypertension clinic. N Z Med J (1990) 0.75
Effect of enalapril on handling of a sodium chloride load by genetically hypertensive and normotensive rats. Clin Exp Pharmacol Physiol (1989) 0.75
Handling of a sodium load by rats on a low sodium intake and frusemide. Clin Exp Pharmacol Physiol (1987) 0.75
Changes in clinical characteristics and drug treatment of hypertension over 40 years at the Dunedin Hypertension Clinic. J Cardiovasc Pharmacol (1990) 0.75
Omissions in advertising. N Z Med J (1973) 0.75
Editorial: Hypertension and depression and their treatment. Aust N Z J Psychiatry (1973) 0.75
Intensification of osmium staining by p-phenylenediamine: paraffin and epon embedding; lipid granules in renal medulla. Stain Technol (1970) 0.75
Flow cytometric analysis of cell cycle of cultured aortic smooth muscle cells from two strains of genetically hypertensive rats. J Cardiovasc Pharmacol (1990) 0.75
24-h exchangeable sodium in genetically hypertensive and normotensive rats. Experientia (1983) 0.75
Effect of verapamil and sodium nitroprusside on hindlimb vascular resistance in New Zealand genetically hypertensive and Japanese spontaneously hypertensive rats. J Hypertens Suppl (1988) 0.75